Participant Sign Up
Caregiver Sign Up

Autism Spectrum Disorder Research Studies

The CADB Medicine Research Program is recruiting for two studies that examine the effects of a potential new treatment for the core symptoms of ASD.

Participants, Click. Here
Caregivers, Click. Here

Fast Facts

Autism Spectrum
Diagnosis

Have a Caregiver Who Can Participate

White Plains, NY

Compensation Provided

About the Studies

If you or a loved one has been diagnosed with Autism Spectrum Disorder (ASD), you may qualify to participate in a study at Columbia University.

This study will examine the effects of a medication called Pimavanserin on behavioral rigidity and restrictive repetitive behavior in individuals with ASD. Besides taking the medication, study procedures include safety and efficacy evaluations with blood sample collections in addition to neurological/physical assessments. Participants will also receive multiple assessments that will allow the study team to provide a report of their areas of strength and difficulties. These may be helpful to their caregivers, teachers, or therapists.

Help advance research on treating symptoms of ASD. Join a study!

Participants, Click. Here
Caregiver, Click. Here

Additional Information

You or your loved one could be eligible to participate in a study if you meet the following criteria.

Eligibility Criteria:

  • 12-40 years old
  • Diagnosed with Autism Spectrum Disorder
  • Speak and understand English
  • Have a parent, primary caregiver, or other adult who spends significant time with the participant
  • Able to swallow study medication with liquid
  • No history of a severe or unstable psychiatric condition
  • No substance abuse disorders in the past 6 months
  • No severe medical conditions in the past 3 months
  • Not pregnant, nursing, or planning to become pregnant during the study
Additional criteria will be screened for each study.

Pimavanserin study:

  • Participants will first come to the clinic for a screening visit, where researchers will determine if they can take part in the study.
  • Once a participant is in the study, they will take either pimavanserin or placebo (a dummy drug) for the first two visits. After the second visit they will take pimavanserin daily for six weeks.
  • At each visit, the researchers will ask the participant how they are feeling, and they will be examined by the doctor. The participant and their caregiver may also be asked to provide some information and complete some tests to see if the medicine is having any effect.

Procedures involved in this study include physical exams, neurological exams, vital signs, blood draws, urine samples, electroencephalogram (EEG), electrocardiogram (ECG), assessments, and questionnaires.

Participants will receive $50-75 per completed visit. Some reimbursement for travel expenses may also be available.

There is no cost for you or your loved one to participate.
Tagged